WO2024003792 - VIRAL DETECTION ASSAYS
National phase entry is expected:
Publication Number
WO/2024/003792
Publication Date
04.01.2024
International Application No.
PCT/IB2023/056721
International Filing Date
29.06.2023
Title **
[English]
VIRAL DETECTION ASSAYS
[French]
DOSAGES DE DÉTECTION VIRALE
Applicants **
CRISPR THERAPEUTICS AG
Baarerstrasse 14
6300 Zug, CH
Inventors
GUDEY, Shyam Kumar
105 West First Street
South Boston, Massachusetts 02127, US
VERMA, Atul
105 West First Street
South Boston, Massachusetts 02127, US
SRA, Kuldip Singh
105 West First Street
South Boston, Massachusetts 02127, US
Priority Data
63/356,833
29.06.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 4072 | |
| EPO | Filing, Examination | 58091 | |
| Japan | Filing | 592 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 31285 |
Total: 94615 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
Methods, compositions and kits for detection of one or more of Human Parvovirus B19 (B19), Human Herpes Virus 6 (HHV6), Human Herpes Virus 7 (HHV7), Human Herpes Virus 8 (HHV8), Epstein Barr Virus (EBV), and Hepatitis A Virus (HAV) in sample(s) are disclosed herein.[French]
L'invention concerne des méthodes, des compositions et des kits permettant la détection d'un ou plusieurs virus parmi le parvovirus humain B19 (B19), le virus de l'herpès humain 6 (HHV6), le virus de l'herpès humain 7 (HHV7), le virus de l'herpès humain 8 (HHV8), le virus d'Epstein-Barr (EBV) et le virus de l'hépatite A (HAV) dans un ou plusieurs échantillons.